Overall rank by patents
#594
Across all tracked assignees
USPTO PatentsView assignee record - 749 granted patents across 25 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A45C (PURSES; LUGGAGE; HAND CARRIED BAGS).
The verdict
Spigen holds 749 US patents across 25 technology areas, rank #594 of 50,000 tracked assignees.
Spigen Korea Co., Ltd. has been granted 749 US utility patents between 2015 and 2025, placing Spigen Korea Co., Ltd. at rank #594 across all assignees tracked by PlainPatent. This portfolio spans 25 distinct Cooperative Patent Classification (CPC) subclasses, averaging 2.0 claims per patent with primary concentration in A45C (PURSES; LUGGAGE; HAND CARRIED BAGS). As a Foreign Corporation, Spigen Korea Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Spigen sits between Pacesetter, Inc. (754 patents, rank #590) and Nuance Communications, Inc. (740 patents, rank #598) - the closest US assignees by grant volume. The composite Innovation Score of 43.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 412 grants, compared with 337 in the 2015–2019 window, a +22% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Spigen Korea Co., Ltd.'s 2.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 25 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Spigen Korea Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PACESETTER, INC.
754 patents
adidas AG
754 patents
Medline Industries, LP
753 patents
SHENZHEN GOODIX TECHNOLOGY CO., LTD.
753 patents
SPIGEN KOREA CO., LTD.
749 patents
The Toronto-Dominion Bank
748 patents
Steering Solutions IP Holding Corporation
747 patents
Shanghai Tianma Micro-electronics Co., Ltd.
743 patents
Nuance Communications, Inc.
740 patents
What this shows Spigen holds 749 patents at rank #594, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #594 in granted patent volume.
Other assignees with the most granted patents in Spigen's primary technology class.
Spigen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 28% higher than 72% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 0.3% |
| 2016 | 19 | 2.5% |
| 2017 | 65 | 8.7% |
| 2018 | 92 | 12.3% |
| 2019 | 159 | 21.2% |
| 2020 | 149 | 19.9% |
| 2021 | 90 | 12.0% |
| 2022 | 3 | 0.4% |
| 2023 | 49 | 6.5% |
| 2024 | 61 | 8.1% |
| 2025 | 60 | 8.0% |
Top 15 of 25 technology areas
Overall rank by patents
#594
Across all tracked assignees
43.6 out of 100
How to use this portfolio
Spigen's 749 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.